Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
The mission of EIIR Trend is to help EIIR buyers in their journey with data, information, and knowledge.
Copyright © 2022. EIIR Trend
This data is based on secondary research and our estimates. No claim is made for authenticity and correctness. If you find any discrepancy please write to firstname.lastname@example.org.